Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan · Delayed Price · Currency is TWD 46.85
+1.55 (3.42%)
Oct 8, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 61.39 billion as of October 8, 2026. It is the 7,071st most valuable company in the world and the 216th biggest in Taiwan. Its market cap has increased by 163.21% in one year.
Market Cap
61.39B
Enterprise Value
59.70B
Revenue
28.93M
Global Rank
Country Rank
#216 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 61.39B, an increase of 1,004.96%. That is a compound annual growth rate of 153.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 61.39B | 206.02% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
| Mar 8, 2024 | 5.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 144.70B |
| Caliway Biopharmaceuticals | 120.54B |
| CHO Pharma | 24.50B |
| Oneness Biotech | 23.06B |
| Sunmax Biotechnology | 21.57B |
| Medigen Vaccine Biologics | 20.38B |
| TaiMed Biologics | 16.72B |
| Ever Supreme Bio Technology | 16.27B |